US Patent

US7301050 — 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs

Composition of Matter · Assigned to Janssen Pharmaceutica NV · Expires 2026-08-02 · 0y remaining

Vulnerability score 35/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects a class of compounds, including 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs, used as PPAR delta modulators.

USPTO Abstract

The invention features 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs, compositions containing them, and methods of using them as PPAR delta modulators to treat or inhibit the progression of, for example, dyslipidemia.

Drugs covered by this patent

seladelpar-lysine (SELADELPAR LYSINE)

Patent Metadata

Patent number: US7301050
Jurisdiction: US
Classification: Composition of Matter
Expires: 2026-08-02
Drug substance claim: Yes
Drug product claim: Yes
Assignee: Janssen Pharmaceutica NV
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.